Current Month 2005
Article Features
  Neutron Brachytherapy May Offer New Hope to Treat Difficult Cancers
New Biopsy Technique Helps Assess Breast Cancer's Spread
Study Shows Greatest Benefit of Chemotherapy in ER-Negative Tumors
New Molecular Classification of Breast Cancer Predicts Response to Chemotherapy
More Research Needed on Complementary Therapies
Scientists Recreate DNA Mending Pathway
Breast Cancer Does Not Appear to Lead to Employment Discrimination
Celecoxib Shows Surprising Activity Against Estrogen Receptors
Researchers Call for Studies on Role of BRCA1 Mutations in Chemotherapy Response
New Breast Cancer Study Shows Hormonal Therapy after Surgery is Not Enough
Use of Estrogen Plus Progestin Associated with Increased Risk for Certain Type of Blood Clot
Breast Cancer May Be Uniquely Sensitive to Inhibitors of P13K Pathway
Breast Conserving Therapy Safe for Hereditary Breast Cancer
International Trial Finds Benefits of Breast MRI in Women at High Risk
Can the Standard Course of Radiation Therapy Following Lumpectomy be Shortened?
Study Finds Continued Reduction in Breast Cancer Incidence with Raloxifene
Stem Cells' Repair Skills Might Be a Link to Cancer
Tamoxifen's Risks Similar in African American and White Women
No Link Found Between Pneumonitis in Breast Cancer Patients And Taxane-Based Chemotherapies, Radiation
Cell Marker Identifies Patients Who Are More Likely to Respond to Taxol
Less Risks for Patients Participating in Early Phase Cancer Drug Trials

Breast MRI Moderately Useful for Detecting Breast Cancer, But Does Not Eliminate Need for Biopsy

In women with breast lesions that are suspicious for cancer, based on clinical examination or mammography, performing a breast MRI has high sensitivity but only moderate specificity for detecting breast cancer, but does not necessarily eliminate the need for tissue sampling, according to a study published in the Journal of the American Medical Association.

Mammography is the primary imaging modality used to detect clinically occult breast cancer, according to background information in the article. However, mammography has limitations in both sensitivity and specificity that have led to exploration of other imaging techniques. Magnetic resonance imaging (MRI) has been evaluated for breast imaging because of its value for assessing soft tissues of the body. Previous research has indicated that additional lesions seen by MRI that are not visible on the mammogram have been reported to be present in between 27 percent and 37 percent of patients. The use of MRI to evaluate women with mammographically or clinically suspicious breast lesions who are undergoing biopsy has shown high potential.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon